NCT05163197View on ClinicalTrials.gov

Transperineal Laser Ablation Treatment (TPLA) for Prostate Cancer (PCa) Registry

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2027

Conditions
Prostate Cancer
Interventions
PROCEDURE

Transperineal Laser Ablation of Prostate Cancer

Minimal invasive transperineal laser ablation treatment for prostate cancer

Trial Locations (1)

Unknown

RECRUITING

Amsterdam University Medical Centers, Amsterdam

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER